This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Oct 2025

Baciforte (Bacillus clausii 4x10^9 cfu/5ml - Oral suspension)

Composition



Bacillus clausii 4x10^9 cfu/5ml

Dosage Form




Oral suspension

Indication



Benefits: Supply probiotic Bacillus clausii to improve intestinal microflora, help to reduce symptoms of poor absorption of nutrients, intestinal disorder and diarrhea due to imbalance of gut microflora




Use for: People with diarrhea, intestinal disorder due to long-term antibiotic use, chemotherapy or intoxication, poor absorption of nutrients 

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile